Oral Paricalcitol for the Treatment of Secondary Hyperparathyroidism in Patients on Hemodialysis or Peritoneal Dialysis - Ross, Edward A.; Tian, Jin; Abboud, Hanna; Hippensteel, Richard; Melnick, Joel Z.; Pradhan, Rajendra S.; Williams, Laura A.; Hamm, L. Lee; Sprague, Stuart M. (American journal of nephrology, 2008)
Keywords: Administration, Oral; Adult; Aged; Aged, 80 and over; Calcium - blood; Ergocalciferols - administration & dosage; Ergocalciferols - adverse effects; Female; Humans; Hyperparathyroidism, Secondary - blood; Hyperparathyroidism, Secondary - drug therapy; Hyperparathyroidism, Secondary - etiology; Kaplan-Meier Estimate; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - therapy; Male; Middle Aged; Original Report: Patient-Oriented, Translational Research; Parathyroid Hormone - blood; Peritoneal Dialysis; Phosphorus - blood; Placebos; Receptors, Calcitriol - metabolism; Renal Dialysis; Treatment Outcome; Chronic renal failure; Chronic renal insufficiency; Secondary hyperparathyroidism; Paricalcitol